MedTrace Logo

Prospective Study of Pregnancy in Women With Cystic Fibrosis

NCT04828382 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 285

Last updated 2025-11-03

No results posted yet for this study

Summary

In this study, the investigators aim to evaluate changes in lung function in women with cystic fibrosis (CF) during pregnancy and for 2 years after pregnancy based on exposure to highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

Conditions

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • National Jewish Health

    collaborator OTHER

  • Cystic Fibrosis Foundation

    collaborator OTHER

  • Amalia Magaret

    lead OTHER

Principal Investigators

  • Raksha Jain, MD · University of Texas

  • Jennifer Taylor-Cousar · National Jewish

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04828382 on ClinicalTrials.gov